Mycobacterium tuberculosis causes widespread, persistent infection, often residing in macrophages that neither sterilize the bacilli nor allow them to cause disease. How macrophages restrict growth of pathogens is one of many aspects of human phagocyte biology whose study relies largely on macrophages differentiated from monocytes in vitro. However, such cells fail to recapitulate the phenotype of tissue macrophages in key respects, including that they support early, extensive replication of M. tuberculosis and die in several days. Here we found that human macrophages could survive infection, kill Mycobacterium bovis BCG, and severely limit the replication of M. tuberculosis for several weeks if differentiated in 40% human plasma under 5%-10% (physiologic) oxygen in the presence of GM-CSF and/or TNF-a followed by IFN-g. Control was lost with fetal bovine serum, 20% oxygen, M-CSF, higher concentrations of cytokines, or premature exposure to IFN-g. We believe that the new culture method will enable inquiries into the antimicrobial mechanisms of human macrophages.
Introduction
Tuberculosis is a major global health problem. Mycobacterium tuberculosis has humans as its only known natural host and macro phages as its predominant cellular niche. However, the study of M. tuberculosis pathobiology in vitro in its natural host species and cell type is hindered by methodologic shortcomings. If differentia tion of primary human macrophages from blood monocytes faith fully recapitulated that in vivo, we would expect the macrophages to impose a prolonged nonreplicating state on M. tuberculosis. This might be achieved at the cost of macrophage death and replace ment, consistent with experiments in zebrafish with Mycobacterium marinum (1, 2) and in mice with Mycobacterium bovis var. BCG (3, 4) that revealed the granuloma to be a dynamic structure. In settings in vitro in which there is no macrophage replacement, the expect ed outcome would be prolonged limitation of M. tuberculosis rep lication followed by death of the macrophages and resumption of M. tuberculosis replication.
The evidence to date is equivocal that human monocytederived macrophages (MDMs) can exert prolonged control over M. tuberculosis's replication in vitro. Investigators often culture the MDMs in aminoglycoside antibiotics before infection with mycobacteria, or even after the infection, in the belief that aminoglycosides only kill extracellular bacteria. However, pinocytosed aminoglycosides reach macrophage phagosomes via pinosomephagosome fusion and contribute substantially to the cells' apparent antibacterial activity (5, 6) . The antimycobacterial effect of streptomycin can persist for over a week after its removal from macrophage cultures (J. Koo and C. Nathan, unpublished observations). To enumerate intracellular M. tuberculosis, investigators often rinse off extracellular bacte ria when replacing media and before harvesting a monolayer. If M. tuberculosis kills the macrophages, wash steps can lead to the same reduction in CFU as if the macrophages killed the M. tuberculosis. Studies in which macrophages treated in a given way are said to "kill" M. tuberculosis sometimes actually report reduced rates of M. tuberculosis's replication, in that the number of M. tuberculosis CFU at the time studied is greater than the number originally ingested. Many studies report that IFNγ hastens replication of M. tuberculosis in MDMs (7) . In vivo, however, IFNγ is a nonredun dant driver of mycobacterial control. Thus, the known genes whose lossoffunction mutations impart Mendelian susceptibility to mycobacterial disease (MSMD; OMIM 209950) are mostly involved in controlling the production of or response to IFNγ (8, 9) . Anti-IFNγ autoantibodies can also confer susceptibility to tuberculosis (10) , while administration of IFNγ to patients with tuberculosis speeds bacterial clearance (11) . Finally, almost all studies of inter action of M. tuberculosis with macrophages in vitro are confined to periods of a few days. In fact, in some prominent reports, replication or control of replication of M. tuberculosis in human macrophages is described in periods of observation as short as 4 hours, about one fifth of M. tuberculosis's replication time in microbiologic media. Latent tuberculosis, in contrast, can last a lifetime. In those who develop active tuberculosis, both progression of disease and che motherapeutic cure usually proceed over months to years. Thus, it would be surprising if physiologically representative macrophages either allowed extensive replication of M. tuberculosis within a few hours or killed M. tuberculosis within a few hours.
Numerous experimental approaches to the in vitro differentia tion of human monocytes have been highly informative for a wide range of questions. With respect to M. tuberculosis infection, how ever, methodologic limitations of existing protocols appear critical. Therefore, we extensively investigated numerous variables for the culture of human MDMs, using two cardinal criteria for physiologic relevance: the macrophages must survive infection by and control the replication of M. tuberculosis for at least 2 weeks. We achieved that standard by extensively modifying conventional methods, altering the source and amount of plasma proteins, the oxygen tension, and the timing, identity, and concentration of exogenous cytokines.
Results

Overview.
We assessed MDM viability by inspecting photomicro graphs of every well in which MDM were cultured in this study. As revealed by counting of nuclei (12) , monolayers that became confluent retained nearly all the nuclei added, supported a many fold increase in the size of cells with single nuclei (13) , and allowed sufficient fusion into multinucleated giant cells to reduce the total number of individual cells by a factor of approximately 5, as illustrated in Supplemental Figure 1A (supplemental mate rial available online with this article; doi:10.1172/JCI57235DS1). In contrast, subconfluence reflected limited cell survival, mini mal cell enlargement, and/or cell detachment. CFU values are reported from monolayers that were 95%-100% confluent, with the following exceptions. In instances in which subconfluence was itself an important result, the estimated percent of subconfluence is reported, with "100" or "*" in the figures signifying complete destruction of the monolayer.
We first prioritized the ability of MDMs to kill BCG under bio safety level 2 (BSL2) conditions. Subsequently, we used more lim ited combinations of variables to optimize the ability of MDMs to restrict the replication of M. tuberculosis under BSL3 conditions. We used no antibiotics at any stage.
We did not wash the cultures at any time after adding cells or bacteria. The number of mycobacteria added was determined in retrospect as described in Methods and converted to a ratio, MOI, calculated as input CFU/input number of monocytes plated. We did not adjust the MOI for the decrease in number of individual MDMs as they fused.
Many of the experiments tested combinations of variables head tohead and revealed that they interacted in combinatorial fash ion. Rather than documenting every combination, subsequent sections summarize basic comparisons without showing data. We then illustrate the impact of selected variables under conditions determined to be otherwise optimal.
In the standard format we ultimately developed, cytokines were tested in two different time windows: from day 0 to 14, which we termed a period of "differentiation," and from day 14 to the end of the experiment, which we called a period of "activation." The activation period typically lasted 2 days before infection and then another 3 weeks following infection with BCG or 2 weeks following infection with M. tuberculosis (Supplemental Figure 1B) . Although the terms "differentiation" and "activation" are arbitrary, they serve to underscore that cytokines had strikingly different effects when added in the two different periods. Because of the profound impact of O 2 tension, we evaluated the role of cytokines in dif ferentiation and activation in two rounds of experiments - first under 20% O 2 and then under 5%-10% O 2 .
Over 3 years we initiated MDM cultures on 100 occasions from a total of 37 donors. MDMs derived on multiple independent occa sions from a given donor behaved consistently when tested under the same conditions, but the results could be consistently different from those for MDMs from another donor. The final assay condi tions reported are those that appeared optimal for MDMs from 24 donors tested headtohead.
Cell isolation, plating density, culture vessels, and medium. As noted above, voluminous data compiled in this series of studies will be summa rized but not shown. Each variable stated to have been found optimal was used to obtain the results that are documented in the figures.
We isolated the mononuclear fraction (monocytes and lym phocytes, contaminated with platelets) by standard FicollPaque discontinuous density separation. We plated the washed mono nuclear fraction directly or subjected the cells to positive sorting with antiCD14 antibody coupled to magnetic beads (Supplemen tal Figure 1B) . Adding back the rest of the mononuclear cells was no better than using the CD14positive cells alone. The donor's PPD status was immaterial. We compared use of antiCD14 anti body at the concentration recommended by the manufacturer or at 25% of that concentration, having demonstrated by flow cytom etry that use of more dilute antibody isolated a relatively higher proportion of CD14 bright cells and a relatively lower proportion of CD14 dim cells, with the same total enrichment of CD14positive cells (93% ± 5%). Results were comparable with both approaches, so we adopted the more economical method.
The CD14positive, monocyteenriched fraction was incubated in tissue culture plates from three different manufacturers. Results with plates from TPP were most reproducible. Results were com parable in 24 and 96well plates. We chose 96well plates for econ omy. The optimum plating density for CD14positive monocytes was 8.5 × 10 4 cells per well in 200 μl (Supplemental Figure 1B) , as in another study (14) . It was critical to mitigate evaporation by fill ing the outer wells with sterile water and rigorously maintaining humidity in the incubators. Optimal results required completing manipulations in room air rapidly.
RPMI1640 was a more effective base medium than DMEM. This was attributable at least in part to the higher concentration of glu cose in the DMEM we tested (4 g/l) than in the RPMI1640 we tested (2 g/l), because adding glucose to RPMI1640 to equal the concen tration in DMEM led to loss of viability of the MDMs. There was no advantage to MDM viability or control of mycobacterial replication if we supplemented the medium with extra larginine, pyruvate or 1,25dihydroxyvitamin D, as long as we used 40% human plasma.
Effect of human plasma. MDMs were differentiated for 2 weeks in RPMI containing various percentages of FCS and then infected with BCG. They failed to control bacterial replication. Moreover, MDM survival varied with the lot of FCS. In contrast, MDMs that were differentiated in human plasma in RPMI survived infection by and controlled replication of BCG. The optimal concentra tion of human plasma was 40%. Effects were equivalent when the plasma was fresh or stored at 4°C for up to 10 weeks and whether the plasma was autologous, heterologous, or pooled. For MDMs from certain donors, heterologous or pooled plasma was supe rior to autologous plasma.
Effect of incubation time. Figure 1A shows results for monocytes or MDMs in RPMI with 40% human plasma without added cytokines in 20% O 2 that were infected with BCG after variable periods of dif ferentiation. Monocytes incubated for 0 or 3 days before infection with BCG sustained replication of the bacillus beginning about 3 days later and died by day 6 or 9, respectively. Monocytes cultured for 1 week before infection largely restrained the growth of BCG for the next 12 days, but then died. MDMs allowed to differentiate for 2 weeks prior to infection survived for 12-14 days, restraining BCG's replication for the first 9 days. Those allowed to differentiate for 3 or 4 weeks survived for a further 2 or 3 weeks after infection, respec tively, but permitted more extensive replication of BCG. We chose 2 weeks of differentiation prior to infection as a standard approach and subsequently validated this in experiments with different O 2 tensions and cytokines and with M. tuberculosis instead of BCG.
In all experiments 30% of the medium in each well was replaced with fresh medium every 3-4 days. Refreshment was critical, and the optimal interval was 3-4 days. If a cytokine was tested, the replenishment medium included the cytokine for the indicated final concentration. By removing the uppermost 60 μl of the medium, we collected a negligible proportion of the added CFU. Thus, refreshment of the medium in this way did not artifactually impact the assessment of bacterial replication.
Effect of IFN-γ and MOI. These two variables proved to be interre lated and so are discussed together. Including IFNγ in the 2week differentiation period led to death of BCG or M. tuberculosis-infect ed MDM (data not shown). Therefore, monocytes were allowed to differentiate for 2 weeks without IFNγ, exposed to IFNγ for 2 days, and then infected with BCG, generally for 3 weeks (Supplemental Figure 1B) . As shown in Figure 1B , a concentration of IFNγ as low as 250 ng/ml was deleterious to MDM viability in the absence of BCG. In the presence of BCG, even lower concentrations of IFNγ were deleterious. BCG was deleterious as well, and its toxicity increased in proportion to the MOI. Strikingly, however, very low concentrations of IFNγ protected MDMs from the toxicity of BCG. The optimal concentration of IFNγ was donor dependent. For the majority of donors, the optimal concentration of Actimmune (a clinically used IFNγ preparation) ranged from 0.5 to 5 ng/ml, well below the concentration used in most studies.
Next we investigated the impact of MOI on MDM control of BCG. After 2 weeks of differentiation, MDMs were treated or not with 3 ng/ml IFNγ, and wells were harvested at intervals over the next 4-6 weeks. With MOI in the range of 0.01-0.3, MDMs remained fully confluent. However, the curve relating MOI to the ability of the MDMs to restrain replication of BCG was bellshaped, just as was the concentrationresponse effect of IFNγ on MDM viabil ity ( Figure 1C and Supplemental Figure 1C ). When the MOI was extremely low (0.03 or 0.01), BCG replicated extensively. When the MOI was 0.3 or 0.1, there was a less than 1 log 10 increase in CFU after 3-5 weeks. Higher MOI led to earlier and more extensive death of the MDMs. We chose an MOI of 0.2 for most experiments.
In sum, the protective effect of IFNγ, often considered the prin cipal macrophageactivating factor (15), was strongly dependent on the time of its addition, its concentration, and the magnitude of the ensuing microbial challenge.
Effect of differentiation in M-CSF, GM-CSF, or GM-CSF plus IL-4.
MDMs were differentiated for 2 weeks in the presence or absence of 50 ng/ml of MCSF, GMCSF, or GMCSF plus IL4. The lat ter combination is often used to differentiate monocytes to den dritic cells. The MDMs were then "activated" or not with 3 ng/ml IFNγ. Two days later they were infected with BCG at MOI 0.1 ( Figure 1D ) or 0.3 (Supplemental Figure 1D ). Results at MOI of 0.1 and 0.3 were identical. MCSF and GMCSF had no effect on MDM viability or control of BCG replication, provided that the MDMs were differentiated in human plasma, which we con firmed contained MCSF (data not shown). However, GMCSF, but not MCSF, could overcome the deleterious effect of differ entiation in FBS. MDMs differentiated in the combination of GMCSF plus IL4 supported extensive replication of mycobac teria and died ( Figure 1D ). Paradoxically, in the cultures with dying MDMs, the number of BCG CFU appeared to decline dras tically. This was an artifact due to the release of the BCG into the medium, where, after 3 days of bacteriostasis, and in contrast to M. tuberculosis, they died (data not shown). The deleterious effect of combined GMCSF plus IL4 was particularly conspicuous in human plasma-supplemented cultures.
From this point on we used the following framework for culture of MDMs: 2 weeks of differentiation in RPMI containing 40% human plasma, with replacement of 30% of the medium every 3-4 days, fol lowed by activation of the cells 2 days before infection ( Figure 1E ).
In summary, a combination of the two additives most common ly used for culture of human monocytes - FBS and MCSF - led to MDMs that were unable to control the replication of BCG and thus died. However, it would be easy to reach the opposite conclu sion - that the MDM decreased BCG viability - when MDMs died and released BCG into the medium.
Impact of diverse cytokines on activation of MDMs to control BCG. MDMs were cultured for 2 weeks in 20% O 2 with 40% human plasma and then activated or not with IFNγ alone at 3 ng/ml; with a panel of cytokines each tested alone at 0.5, 5, or 50 ng/ml or at those concentrations along with 3 ng/ml IFNγ; or with all the cytokines except IL4 and IL13 pooled at 50 ng/ml each, both with and without 3 ng/ml IFNγ. The panel included IL1β, IL4,  IL8, IL12, IL13, IL15, IL18, IL22, IL23 , TGFβ, TNFα, mono cyte chemotactic protein-1 (MCP1), MCSF, GMCSF, and VEGF. Tests with MCSF and GMCSF differed from those discussed ear lier, in that the cytokines were now added during the activation period, rather than during the differentiation period. Tested individually in the same 5 experiments, 7 of the 15 other cytokines also helped fully confluent cultures of MDMs restrict BCG's replication, although none as well as IFNγ ( Figure 2B ). List ed in decreasing order of effectiveness along with the concentra tion that proved optimal, these were GMCSF (0.5 ng/ml), TNFα (50 ng/ml), IL13 (0.5 ng/ml), IL15 (50 ng/ml), IL4 (0.5 ng/ml), IL12 (5 ng/ml), and IL1β (50 ng/ml). Concentrations of IL4 or IL13 greater than 0.5 ng/ml led to destruction of the BCG infected MDMs (Supplemental Figure 2, A and B) . The other 8 cytokines tested singly led to bacterial counts similar to or higher than those in MDMs given no cytokines (Supplemental Figure 2,  A and B) . The combination of cytokines at 50 ng/ml gave results comparable to those using GMCSF alone at 0.5 ng/ml ( Figure 2B ). The impact of IFNγ was minimally affected by the addition of any of the other cytokines tested. With the cytokines that were weakly effective on their own, there were additive or slightly subadditive effects, but no synergy, in combinations with IFNγ (Supplemen tal Figure 2 , C and D).
In summary, IFNγ, GMCSF, and TNFα were the most effec tive cytokines of those tested during the activation period for enabling MDMs to survive infection by and control replication of BCG over a 3week period. iologic O 2 levels can improve the functional performance of macro phages. Accordingly, we differentiated MDMs for 2 weeks and infect ed them with BCG for 8-24 days using 5% CO 2 along with O 2 at 20%, 10%, 5%, or 1% throughout. MDMs were fully confluent through the 3.5week period of infection when the O 2 was 20% or 10%. At 5% O 2 the MDMs were sometimes slightly subconfluent. At 1% O 2 , the MDMs were smaller and markedly subconfluent ( Figure 2C ). Strikingly, while BCG replicated by 1 log 10 over 3.5 weeks in MDMs with 20% O 2 , there was 0.5 log 10 killing (that is, approximately 3.3fold reduction in CFU below the number initially added) under 10% O 2 , 1 log 10 killing at 5% O 2 , and 2 log 10 killing at 1% O 2 ( Figure 2D ). We chose 10% O 2 for most subsequent experiments.
Next, by using a glovebox, we tested the impact of strictly and continuously maintaining 10% O 2 at all times, including when adding IFNγ, inoculating the cultures with BCG, and refreshing the medium every 3-4 days, compared with a less cumbersome approach in which we removed the cultures from lowO 2 boxes long enough to perform these operations rapidly in room air. Brief exposure to room air made no difference (data not shown). There after, we used the discontinuous method of incubation in low O 2 .
In summary, physiologic tissue levels of O 2 enabled MDMs to kill BCG, while cells otherwise cultured identically at 20% O 2 sup ported BCG's extensive replication.
Revisiting the activation of MDMs for killing BCG. Having selected 10% O 2 , 5% CO 2 as the gas phase, we revisited the issue of activation of MDMs following a 2week differentiation in RPMI with 40% autologous human plasma. During the next 2 days, the MDMs were exposed to IFNγ alone, a panel of cytokines tested individu ally, or both and then infected with BCG at an MOI of 0.1. The cytokine exposure was continued throughout the next 3 weeks. The cytokine panel included the 15 listed earlier plus 10 more: IL6, IL10, IL17, IL17F, IL32, CD40L, CX3CL1, WNT3a, leptin, and TNFSF11, each tested at 5 or 50 ng/ml, as well as a pool of all except IL4 and IL13, comprising 27 cytokines, at 50 ng/ml each. Figure 3B ) (the optimal concentration is given in parentheses): IFNγ (3 ng/ml), GMCSF (50 ng/ml), TNFα (50 ng/ml), IL13 (5 ng/ml), and IL4 (0.5 ng/ml). However, in some of these experiments, IL4 or IL13 led to partial destruction of the monolayers. Tested singly, the 22 other cytokines led to bacterial counts similar to or higher than in MDMs given no cytokines (Supplemental Figure 3, A and B) .
In summary, 6 of 28 cytokines tested during the activation phase could enhance the ability of MDMs to kill BCG, but most of the MDMs' antiBCG activity was imparted by the use of physiologic tissue levels of O 2 . The effective cytokines included several associ ated with both classically and alternatively activated macrophages in the context of mouse immunology.
Turning to M. tuberculosis and revisiting activation. Next, we set BCG aside and focused on the ability of MDMs to survive M. tuberculosis infection and restrict the replication of M. tuberculosis. We used MDMs "differentiated" for 2 weeks in RPMI with 40% human plasma under 10% O 2 and 5% CO 2 . With most donors' MDMs, differentia tion for 2 weeks without added cytokines led to death of the MDMs during a subsequent 3week infection with M. tuberculosis. Thus, to improve the efficiency of testing and to allow the comparison of differentiation with and without added cytokines that is presented in subsequent sections, we limited the infection period to 2 weeks. Figure 4A presents results from a donor whose MDMs responded to added IFNγ during the activation phase. Figure 4B shows results from a donor whose cells acted as if they had already been exposed to IFNγ and did not respond to the added cytokine. Such cultures may have produced their own IFNγ (19) , but this was not tested. In all cases, we observed a concentration dependent response to GMCSF, TNFα, IL12, and IL15 ( Figure 4, A and B) . In contrast to BCG, we did not observe net killing of M. tuberculosis. Neverthe less, under 10% O 2 , MDMs survived a 2week infec tion with M. tuberculosis and markedly limited the pathogen's replication.
Infecting with M. tuberculosis after revisiting differentiation: contrasting effects of GM-CSF and M-CSF.
Results from MDMs differentiated in RPMI with 40% human plasma without exogenous cytokines are shown in Figure 4 , A and B. As judged by lim ited cell enlargement, MDMs from 2 of 24 donors differentiated poorly without the aid of exogenous cytokines and died during the subsequent M. tuberculosis infection. We could prevent this by differen tiating all 24 donors' MDMs in either GMCSF or TNFα. Results with GMCSF are described here and those with TNFα in the next section.
First, we directly compared differentiation in GMCSF and MCSF, because MCSF is widely used to differentiate mouse macrophages from bone mar row precursors and human MDMs from monocytes. The conditions were now substantially different from those in which we earlier made the compari son: culture in 10% O 2 rather than 20% O 2 ; activa Figure 4C and Supplemental Figure 4A , 2week dif ferentiation in the presence of MCSF (50 ng/ml) led to subsequent destruction of the MDM monolayers in association with extensive proliferation of M. tuberculosis, no matter with what cytokines the MDMs were activated for 2 days before and then during the 2week infection. There was one exception: GMCSF activation at day 14 was able to revert the poor results seen with differentiation in MCSF. Otherwise, MDMs differentiated with MCSF allowed M. tuberculosis to replicate by a factor of approximately 100fold by the time the monolayers were reduced to about 50% confluence.
In contrast, 2week differentiation in the presence of GMCSF (50 ng/ml) led to fully confluent monolayers throughout 2 weeks of M. tuberculosis infection. Replication of M. tuberculosis was limited to about 8fold without IFNγ and about 4fold with IFNγ ( Figure 4C and Supplemental Figure 3A) . The most effective cytokine during the activation phase was TNFα. As shown in Figure 5A , which is representative of 5 independent experiments, as little as 0.5 pg/ml of GMCSF in the 2week differentiation period allowed morpho logic differentiation of MDMs, but MDMs were only protected from destruction by M. tuberculosis over a subsequent 2week period when the GMCSF was used at concentrations of at least 50 pg/ml. From multiple experiments with different donors, we chose 0.5 ng/ml as the standard concentration for GMCSF during the differentiation phase (Supplemental Figure 4B) .
We validated these finding with MDMs from 3 donors in each of 2 experiments by performing differentiation with 0.5 ng/ml GMCSF ( Figure 5B and Supplemental Figure 3C Figure 3D ) or by adding fresh autologous lymphocytes enriched for expression of CD2, CD3, CD4, or CD8 or remaining after depletion of CD14 + cells from the mononuclear fraction, 2 days prior to infec tion with M. tuberculosis (Supplemental Figure 3, E and F) .
In summary, MCSF, the cytokine most widely used for macro phage differentiation in vitro, was highly counterproductive for MDM control of virulent M. tuberculosis, just as seen when using 20% O 2 and infecting the MDMs with BCG. In contrast, GMCSF was a highly potent differentiation factor.
TNF-α can substitute for GM-CSF in the differentiation of MDMs that restrict replication of M. tuberculosis. Next, we tested the "differentiat
ing" effect of the other 27 cytokines in the panel that was tested earlier in the activation phase. Monocytes differentiated with IFNγ (50 ng/ml) attained the morphologic hallmarks of differentiation for the first few days, but died over the following week. Several other cytokines supported morphologic differentiation (enlarge ment) of MDMs, namely IL32 (50 ng/ml) (20) , IL15 (5-50 ng/ml) (21) , and MCSF (5-50 ng/ml), but the resulting MDMs were unable to control the growth of M. tuberculosis. Only TNFα (opti mal concentration, 0.5 ng/ml) provided similar results to those obtained with GMCSF (data not shown).
To identify the best combination and concentration of the two most effective cytokines during the "differentiation" process, MDMs were differentiated with no exogenous cytokines or with TNFα (0.5 or 5 ng/ml), GMCSF (0.5 ng/ml), or GMCSF (0.5 ng/ml) plus TNFα (0.5 or 5 ng/ml) for 14 days under 10% O 2 ( Figure 6A and Supplemental Figure 4A ) or 5% O 2 ( Figure 6B and Supple mental Figure 4B ). On day 14, MDMs were activated with IFNγ (2.5 ng/ml) or with 8 other cytokines. The MDMs were infected with M. tuberculosis on day 16 , and CFU were determined 2 weeks Figure 4B) .
In summary, under 5%-10% O 2 , MDMs differentiated with very low concentrations of GMCSF and TNFα and then activated with very low concentrations of either IFNγ or TNFα could extensively restrict the replication of M. tuberculosis over a 2week period without undergoing microscopically detectable cell death and without ever having been exposed to antibiotics.
Surface marker profiles of MDMs differentiated in different ways. Next, we compared the cell surface marker profile of MDMs differentiat ed for 2 weeks using either the new regimen, GMCSF (0.5 ng/ml) plus TNFα (0.5 ng/ml), or a more conventional regimen, MCSF (50 ng/ml). In two independent experiments with cells from dif ferent donors, flow cytometric analysis revealed no contamination by CD19 + B cells, CD3 + T cells, or CD56 + NK cells in either case. Of the 29 markers tested, the 20 that were positive revealed only two minor, qualitative differences for MDMs prepared by the differ ent regimens ( Figure 4D and Supplemental Figure 4E ): small sets of CD62L + (Lselectin) and CD40 + MDMs were detected after cul ture with GMCSF plus TNFα but not after culture with MCSF. Moreover, at the quantitative level, there was only one substantive difference in marker expression: MDMs differentiated with MCSF expressed higher levels of CD14 than those differentiated with GMCSF plus TNFα. In sum, surface marker profiling provided little clue to the striking functional distinctions between MDMs differentiated in these two ways.
Impact of microbiologic culture conditions on the susceptibility of M. tuberculosis to control by MDMs. Having emphasized the use of physiologic O 2 levels for culture of MDMs, we considered what impact physi ologic conditions of O 2 and pH might have on the M. tuberculosis with which the MDMs were infected. To explore this, we cultured M. tuberculosis for 1 week in 7H9 microbiologic medium at the cus tomary pH of 6.8 under 20% O 2 or in 7H9 at pH 5.5 (closer to the pH of the phagolysosome of activated macrophages) under 1% O 2 before infecting MDMs. In two experiments with cells from differ ent donors, control of M. tuberculosis replication was indistinguish able with either method of preculture (Supplemental Figure 5G) .
Reexamination of the effect of exogenous vitamin D. Under culture conditions we would now consider suboptimal, vitamin D has promoted the ability of human MDMs to control M. tuberculosis (22, 23) . As noted earlier, we found no effect of adding 1,25dihy droxyvitamin D to culture medium that contained 40% plasma. Having refined the conditions of differentiation and activation, we reexamined this question. MDMs from 2 different donors were differentiated for 2 weeks under 5% O 2 with GMCSF plus TNFα in RPMI with 40% plasma and then activated or not for 2 days with 1,25dihydroxyvitamin D (10 nM or 100 nM) before infection with M. tuberculosis or BCG (Supplemental Figure 5, I and J) . Alterna Figure 5C ). Under 7.5% O 2 , the average extent of replication of M. tuberculosis was 2.5 divi sions over 2 weeks (Supplemental Figure 5, A and B) . After MDMs were differentiated with GMCSF and TNFα, activation by IFNγ restricted the replication of M. tuberculosis with a high level of statistical significance (P = 6 × 10 -5 in Figure 7A ; P = 1 × 10 -11 in Figure 7B ). As alternative activating agents, both GMCSF and TNFα also helped confluent cultures of MDMs restrict replica tion of M. tuberculosis, but not as well as IFNγ.
Discussion
This study demonstrates that human monocytes can be differenti ated in vitro into macrophages that reproducibly survive infection by and markedly slow the replication of M. tuberculosis over a 2week period, without exposure to antibiotics at any time and without wash steps that risk conflating macrophage death or detach ment with microbiologic control. The same MDMs kill BCG. To our knowledge, this degree of control of mycobacteria by human MDMs has not previously been reported. Figure 8A puts these results into perspective with reference to the approximate number of divisions that M. tuberculosis and BCG undergo in a 24hour period. (In the following discussion, we use the terms "divisions" and "replications" to refer to the number of doublings it would require to produce the observed increase in CFU if there were no bacterial death. In reality, there may be a greater number of doublings that compensates for an unmeasured amount of bacterial death.) In media selected to support maximal rates of replication, these mycobacteria divide about once per 20 hours. In a recent study in which MDMs were differentiated with standard methods that included use of FBS and MCSF, BCG replicated in the MDMs approximately 0.6 times per 24 hours (24) . Our data con firm that result for those methods. In contrast, using our revised approach, MDMs allowed no net replication and instead reduced the number of viable BCG by about 90% over 3 weeks. The latter results are closer to those reported for BCG in activated mouse bone marrow-derived macrophages (moBMMs) over 5 days (24) . Turning to M. tuberculosis, moBMMs that had not been exposed to antibiot ics typically restricted mycobacterial replication to approximately 0.25 divisions per 24 hours, but then died around day 6 (A. Venugo pal, P. Rath, and C. Nathan, unpublished observations). In contrast, human MDMs prepared as described here limited the growth of M. tuberculosis to approximately 0.1 division per 24 hours and survived longer than 2 weeks ( Figure 8A ). Considering both the extent and duration of control, this is to our knowledge the closest that human MDMs have come in vitro to mimicking the control of M. tuberculosis by macrophages in the immunocompetent human host.
The critical importance of physiologic tissue levels of O 2 docu mented here confirms the report of Meylan et al. (16) . Thus, as with lymphocytes (25) Several agents routinely used to differentiate and activate human macrophages in vitro proved detrimental altogether, or at conven tional concentrations, or when applied at certain times, by the crite ria of MDM resistance to mycobacteria and control of mycobacterial replication. For example, human MDMs derived in FBS were mark edly inferior to those derived in human plasma with respect to these criteria. Such cells appear to be useful models of human MDM physi ology in other assays. Similarly, MCSF allowed for excellent morpho logic differentiation of MDMs, but mycobacteria rapidly destroyed them. IFNγ, a critical cytokine for MDM activation, was detrimental when applied during the period of differentiation. Moreover, exces sive concentrations of IFNγ hastened replication of M. tuberculosis in MDMs, even though lower concentrations had the opposite effect. The critical dependence of IFNγ's effects on timing and concentra tion may help explain seemingly discrepant findings in some earlier studies (7) . More important, the contrasting effects of IFNγ at dif ferent concentrations and times may help explain why IFNγ is nec essary for control of M. tuberculosis and is produced by T cells from immunocompetent people with latent M. tuberculosis infection that are challenged with antigens expressed by M. tuberculosis, and yet such people do not routinely eradicate latent M. tuberculosis infection.
Of the 28 cytokines tested, GMCSF and/or TNFα afforded the most successful differentiation, whereas IFNγ and TNFα afford ed the best activation. IFNγ and TNFα are the two cytokines whose critical roles in the control of human tuberculosis are best documented by genetic deficiency states (9) , acquired predisposi tion to mycobacterial disease due to autoantibodies to IFNγ (10), administration of recombinant IFNγ to treat multidrugresistant tuberculosis (26) , or administration of therapeutic agents that neutralize TNFα in the treatment of inflammatory diseases (27) .
There is still some way to go to achieve the goal of recapitulat ing the differentiation of human tissue macrophages in vitro. One shortcoming of the present method was that the MDMs did not express iNOS (A. CunninghamBussel, G. Vogt, and C. Nathan, unpublished observations). In contrast, macrophages in humans with inflammatory and infectious disorders, including tuber culosis, often express iNOS (28) (29) (30) (31) . Nonetheless, the methods presented here should prove useful in determining how MDMs control replication of M. tuberculosis and how M. tuberculosis even tually escapes control, as well as in studies of other aspects of the physiology of human macrophages.
Methods
Preparation of monocytes and MDMs by the optimized method. Heparinized blood was collected by venipuncture from healthy donors who provided informed consent under an IRBapproved protocol. Blood was mixed with an equal volume of RPMI1640 (GIBCO, Invitrogen) lacking phenol red and supplemented with 1 mM GlutaMAX (Invitrogen) and centrifuged above FicollPaque (GE Healthcare) for 20 minutes at 500 g at 20°C. The diluted plasma above the PBMC layer was collected and centrifuged for 30 minutes at 2,000 g at 20°C. The supernatant was centrifuged again for 60 minutes at 2,000 g at 20°C. The final supernatant was stored at 4°C and used to prepare fresh medium throughout the experiment.
Monocytes were isolated from the mononuclear cell layer in the Ficoll Paque centrifugation by positive immunomagnetic selection with antibody against CD14 (MACS; Miltenyi Biotec) according to the manufacturer's instructions, with two exceptions. BSA was replaced by 7% autologous plasmaRPMI for purification because some lots of BSA proved toxic. Moreover, we used the antiCD14 antibody at 25% of the concentration recommended by the manufacturer.
RPMI1640 contained glucose at 2 g/l. The culture medium also con tained human plasma at an optimal concentration of 40%. Effects were equivalent when the plasma was fresh or stored at 4°C for up to 10 weeks and whether the plasma was autologous, heterologous, or pooled. For MDMs from certain donors, heterologous or pooled plasma was supe rior to autologous plasma. Every 3-4 days 30% of the medium in each well was replaced with fresh medium including cytokines. Refreshment was critical, and the optimal interval was 3-4 days.
The CD14positive, monocyteenriched fraction was incubated in tis sue culture plates from TPP. Results were comparable in 24 and 96well plates. In 96well plates, the optimum plating density for CD14positive monocytes was 8.5 × 10 4 cells per well in 200 μl. It was critical to miti gate evaporation by filling the outer wells with sterile water and rigorously maintaining humidity in the incubators. Optimal results required com pleting manipulations in room air rapidly.
Cells were differentiated for 2 weeks in RPMI with 40% human plasma with GMCSF and TNFα (0.5 ng/ml each) under 5%-10% O2 and 5% CO2 at 37°C in a humidified atmosphere in a chamber flushed with N2 under the control of a PRoOX sensor and ProCO2 regulator (BioSpherix). They were then activated for 2 days with IFNγ (2.5 ng/ml) and then infected with M. tuberculosis at an MOI of 0.1-0.2 and followed for at least 2 weeks in the same atmosphere. The cytokines used for differentiation contin ued to be provided with the changes of 30% of medium every 3-4 days except the day of infection.
Cytokines. We used IFNγ (Actimmune) from Boehringer because its potency in this assay was higher than that of IFNγ from another sup plier (Supplemental Figure 5F ). Other cytokines were from R&D Sys tems, with BSA as a carrier. Cytokines were diluted in PBS and frozen at -80°C in aliquots used once.
M. tuberculosis. M. tuberculosis Erdman was grown at 37°C in Middlebrook
7H9 broth (Difco; BD) supplemented with 0.2% glycerol, 0.5% BSA, 0.2% dextrose, and 0.085% NaCl without detergent and frozen in logphase (OD at 580 nm, 0.6-0.8) in the same medium with 20% glycerol. Inocula were prepared in MDM culture medium. Inocula were quantified retrospectively by dilution in PBS with 0.5% (final concentration) Triton X100, plating on agar (Middlebrook 7H11, 10% oleic acidalbumindextrosecatalase enrich ment; Difco, BD), and enumeration of CFU at 2 weeks.
Flow cytometry. For analysis of cell surface marker expression, MDMs were differentiated for 2 weeks and then detached using trypsin (1.6 μg/ml) and EDTA (2 mM) in PBS. MDMs were treated with Fc receptor blocking agent (Miltenyi Biotec) and stained for 1 hour at 4°C by using antibodies and appropriate isotype controls from BD. Samples were analyzed on a BD LSR II flow cytometer.
Macrophage infections. MDMs were infected at 16 days at an MOI of 0.1-0.2. We did not wash out extracellular bacteria, as pilot experiments demon strated no difference in outcome whether or not MDMs were washed with warm medium 4 hours after inoculation. At the time points of interest, the appearance of each well was recorded by photomicroscopy. Then an aliquot of medium (100 μl) was removed and reserved. Macrophages were lysed by adding 100 μl PBS containing 1% Triton X100 and mixing the well contents. The reserved medium from the same well was then pooled with the lysate, and bacteria were enumerated by plating duplicate serial dilutions on two agar plates each. Thus, there was no wash step prior to lysing macrophages, and all bacteria in the well were enumerated. 
